Jake Shortt,
Galettis, Peter
Cheah, Chan Y.
Davis, Joanne
Ludford-Menting, Mandy
Link, Emma K.
Martin, Jennifer H.
Koldej, Rachel
Ritchie, David
Funding for this research was provided by:
National Health and Medical Research Council (GNT1067516, GNT1067516)
Victorian Cancer Agency & Snowdome Foundation, Australia (SNOW04)
Article History
Received: 25 September 2022
Accepted: 13 January 2023
First Online: 28 January 2023
Declarations
:
: The study was approved by Melbourne Health Human Research Ethics Committee (Ref: 2014.127) and conducted according to the provisions of the Declaration of Helsinki and International Conference on Harmonisation Guidelines for Good Clinical Practice. All subjects provided informed consent before enrolment. This trial was registered at clinicaltrials.gov; NCT02468687.
: Not applicable.
: JS and DR are inventors on patent WO2011160170A1 ‘stimulating immune response’. There are no other competing interests related to the published work.